BIOZENTA ONCOLOGY

About BIOZENTA ONCOLOGY

We are manufacturer and exporter of Oncology, General Range and Critical Care Finish Formulations. The formulation facility has an ultramodern, well equipped facility with dedicated block for the manufacturing of Oncology products and General Injectables (Liquid Injectables, Lyophilized Injectables, Prefilled Syringes, Tablets and Capsules). Plant is WHO-cGMP Certified; state GMP & GLP & has accreditation from Kenya, Cambodia, Yemen, Philippines, & Malawi and awaited Srilanka, Nepal, ...

Certifications
  • IN
  • 2023
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
  • Khasra No. 59, 60 & 61, Bela Bathri, Haroli, 174301, UNA, Hima, India
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from BIOZENTA ONCOLOGY (5)

  • Abiraterone Acetate Tablets USP 250/500 mg

    Product Abiraterone Acetate Tablets USP 250/500 mg

    A White to off-white coloured elongated shaped biconvex uncoated tablet having break line on one side and plain on another side. Abiraterone Acetate treats prostate cancer that has spread to other parts of the body.
  • Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    Product Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    A White or almost white Lyophilized powder filled in 5 ml clear tubular glass vial. Goserlin Injection is used for the treatment of prostate cancer in men and for breast cancer, endometriosis and uterine fibroids in women. In combination with some other medicine, it is used in the treatment of female infe...
  • Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    Product Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    A reddish orange colored lyophilized cake filled in 5 ml amber glass vial. Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
  • Treosulfan For Injection 1/5 mg/vial

    Product Treosulfan For Injection 1/5 mg/vial

    Vials containing 1 g or 5 g treosulfan. Powder for solution for injection/infusion. A white crystalline odourless powder. Treosulfan is indicated for the palliative treatment of epithelial ovarian cancer.
  • Triptoreline Injection 3.75/11.25/22.5 mg/vial

    Product Triptoreline Injection 3.75/11.25/22.5 mg/vial

    White to off white color lyophilized powder filled in clear tubular glass vial. Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer. Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency...

BIOZENTA ONCOLOGY Resources (1)

  • Brochure Company Brochure

    We are manufacturer and exporter of Oncology/Anticancer, General Range and Critical Care Finish Formulations. The formulation facility is WHO GMP certified and has an ultramodern, well equipped, dedicated setup for manufacturing of Liquid Injectables, Lyophilized Injectables, Prefilled Syringes, Tablets and Capsules.